MetLife Investment Management’s Innovex International INVX Stock Holding History

MetLife Investment Management’s Portfolio INVX Stock Details INVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15.9M	Sell	651,477 -177,280	-21%	-$4.45M	0.08%	235
2025 Q4	$18.1M	Buy	828,757 +20,873	+3%	+$436K	0.09%	194
2025 Q3	$15M	Buy	807,884 +210,894	+35%	+$3.51M	0.07%	254
2025 Q2	$9.32M	Buy	596,990 +576,960	+2,880%	+$8.87M	0.05%	339
2025 Q1	$360K	Sell	20,030 -585	-3%	-$9.94K	﹤0.01%	1884
2024 Q4	$288K	Hold	20,615	–	–	﹤0.01%	2101
2024 Q3	$303K	Hold	20,615	–	–	﹤0.01%	2063
2024 Q2	$383K	Buy	20,615 +2,717	+15%	+$52.7K	﹤0.01%	1871
2024 Q1	$403K	Hold	17,898	–	–	﹤0.01%	1794
2023 Q4	$416K	Hold	17,898	–	–	﹤0.01%	1801
2023 Q3	$504K	Sell	17,898 -768	-4%	-$20.8K	﹤0.01%	1632
2023 Q2	$434K	Hold	18,666	–	–	﹤0.01%	1790
2023 Q1	$536K	Hold	18,666	–	–	﹤0.01%	1598
2022 Q4	$507K	Hold	18,666	–	–	﹤0.01%	1637
2022 Q3	$364K	Buy	18,666 +1,677	+10%	+$38.9K	﹤0.01%	1870
2022 Q2	$438K	Sell	16,989 -2,618	-13%	-$79.8K	﹤0.01%	1757
2022 Q1	$732K	Buy	19,607 +6,881	+54%	+$198K	﹤0.01%	1532
2021 Q4	$250K	Hold	12,726	–	–	﹤0.01%	1921
2021 Q3	$320K	Hold	12,726	–	–	﹤0.01%	1784
2021 Q2	$431K	Hold	12,726	–	–	﹤0.01%	1657
2021 Q1	$423K	Sell	12,726 -3,273	-20%	-$112K	﹤0.01%	1626
2020 Q4	$474K	Hold	15,999	–	–	﹤0.01%	1516
2020 Q3	$396K	Hold	15,999	–	–	﹤0.01%	1494
2020 Q2	$477K	Hold	15,999	–	–	0.01%	1404
2020 Q1	$488K	Hold	15,999	–	–	0.01%	1231
2019 Q4	$751K	Hold	15,999	–	–	0.01%	1243
2019 Q3	$803K	Hold	15,999	–	–	0.01%	1172
2019 Q2	$768K	Hold	15,999	–	–	0.01%	1237
2019 Q1	$734K	Sell	15,999 -21,766	-58%	-$855K	0.01%	1223
2018 Q4	$1.13M	Sell	37,765 -1,169	-3%	-$47.2K	0.01%	971
2018 Q3	$2.03M	Sell	38,934 -3,163	-8%	-$165K	0.02%	851
2018 Q2	$2.16M	Buy	42,097 +173	+0.4%	+$8.06K	0.03%	769
2018 Q1	$1.88M	Sell	41,924 -156	-0.4%	-$7.63K	0.02%	794
2017 Q4	$2.01M	Buy	+42,080	New	+$1.88M	0.02%	786

Other funds holding INVX

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MetLife Investment Management's INVX Position: Q1 2026 in Review

MetLife Investment Management reduced its Innovex International (INVX) stake by 21% in Q1 2026, selling an estimated $4.45M and leaving 651,477 shares worth $15.9M. The position accounts for 0.08% of the portfolio, ranked #235.

MetLife Investment Management first reported a position in INVX in Q4 2017 and has held it in 34 quarters since. The position peaked at $18.1M in Q4 2025. 209 funds tracked by Wall St. Rank hold INVX as of Q1 2026.

MetLife Investment Management held 651,477 shares of Innovex International worth $15.9M as of Q1 2026.
MetLife Investment Management sold 177,280 Innovex International shares in Q1 2026, an estimated $4.45M.
Innovex International made up 0.08% of MetLife Investment Management's portfolio in Q1 2026, its #235 holding.
MetLife Investment Management first reported a position in Innovex International in Q4 2017 and has held it in 34 quarters since.
MetLife Investment Management's Innovex International position peaked at $18.1M in Q4 2025.
209 funds tracked by Wall St. Rank held Innovex International as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.